Moody Aldrich Partners LLC

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 936941 MARBLEHEAD, MA

Position in CRNX

as of Mar 31, 2026 · filed Apr 20, 2026 Compact

Position Value

$6,662,468

+$1,522,650 QoQ

Shares Held

183,438

+66.1% QoQ

Ownership

0.174%

of shares outstanding

% of Portfolio

1.22%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 35.799016561454.ToString("F0")% Shared 29.55439985172102.ToString("F0")% None 34.646583586824974.ToString("F0")%

Healthcare · as of Mar 31, 2026

Moody Aldrich Partners LLC holds $96,976,320 across 28 Biotechnology names. CRNX ranks #4 (6.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PRAX	Praxis Precision Medicines, Inc.	21,688	$6,987,656
2	DNTH	Dianthus Therapeutics, Inc. /DE/	82,129	$6,892,265
3	CAPR	Capricor Therapeutics, Inc.	226,028	$6,871,251
4	CRNX	Crinetics Pharmaceuticals, Inc. This page	183,438	$6,662,468
5	ORKA	Oruka Therapeutics, Inc.	135,061	$6,624,742
6	NKTR	Nektar Therapeutics	89,527	$6,441,467
7	AXSM	Axsome Therapeutics, Inc.	33,973	$5,742,116
8	PTGX	Protagonist Therapeutics, Inc	53,893	$5,680,322

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$6,662,468	183,438	+66.1%	Shares	Sole	2026-04-20
2025-12-31	$5,139,818	110,415	-4.4%	Shares	Sole	2026-01-30
2025-09-30	$4,812,365	115,543	-16.1%	Shares	Sole	2025-10-21
2025-06-30	$3,963,012	137,796	-1.5%	Shares	Sole	2025-08-04
2025-03-31	$4,692,413	139,905	-3.1%	Shares	Sole	2025-04-29
2024-12-31	$7,381,433	144,366	+3.8%	Shares	Sole	2025-01-23
2024-09-30	$7,109,543	139,130	-7.4%	Shares	Sole	2024-10-22
2024-06-30	$6,726,696	150,183	+166.3%	Shares	Sole	2024-07-24
2024-03-31	$2,640,177	56,402	-9.0%	Shares	Sole	2024-04-30
2023-09-30	$1,843,255	61,979	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.